BPG is committed to discovery and dissemination of knowledge
Observational Study
©The Author(s) 2026.
World J Gastrointest Endosc. Feb 16, 2026; 18(2): 116518
Published online Feb 16, 2026. doi: 10.4253/wjge.v18.i2.116518
Table 5 Multivariate analysis to assess the predictors of 3-month mortality
VariablesModel 1 (> 50% in bilirubin by day 7)
Model 2 (Bilirubin < 3 mg/dL by day 15)
Odds ratio (95%CI)
P value
Odds ratio (95%CI)
P value
All patients
Age1.013 (0.967-1.062)0.5821.011 (0.964-1.060)0.654
Benign etiology0.116 (0.013-1.015)0.0520.128 (0.014-1.127)0.064
No AKI at baseline0.136 (0.031-0.601)0.0090.194 (0.041-0.927)0.040
Failure to achieve > 50% in bilirubin by day 72.075 (0.522-8.254)0.300--
Failure to achieve bilirubin < 3 mg/dL by day 15--5.396 (1.370-21.254)0.016
Malignant etiology
Age1.024 (0.971-1.079)0.3851.017 (0.965-1.072)0.530
No AKI at baseline0.103 (0.020-0.541)0.0070.154 (0.027-0.886)0.036
Failure to achieve > 50% in bilirubin by day 71.965 (0.457-8.455)0.364--
Failure to achieve bilirubin < 3 mg/dL by day 15--6.915 (1.496-31.963)0.013


Write to the Help Desk